2023 MN Legislative Session: Wins for Patients & Primary Care

The 2023 Minnesota Legislative Session has ended. In addition to passing a balanced budget for the next two-year period, the Minnesota Legislature passed many bills that the Minnesota Academy of Family Physicians (MAFP) strongly supported, including the All-Payer Claims Database update, audio-only telehealth coverage, rural health care workforce funding, firearm safety measures and more.

While this is being referred to as a historic session for the number of bills passed, it was clearly a good (policy) year for family physicians and their patients.

MN Legislative Update: What to Expect in the Last Weeks of Session

Minnesota Academy of Family Physicians (MAFP) lobbyist Dave Renner, CAE, shares what to expect in the remaining weeks of the legislative session and provides an update on actions around the MAFP’s legislative priority areas.

MN Legislative Update: Gun Violence Prevention, the PRO Act, Mid-Year Formulary Changes + More

Minnesota Academy of Family Physicians (MAFP) lobbyist Dave Renner, CAE, shares an update from the Capitol, highlighting action on gun violence prevention legislation, limiting mid-year formulary changes, updating the All-Payers Claims Database and banning conversion therapy plus the passage of the Patient Reproductive Options Act.

Minnesota Legislative Session: 2023 Preview

Minnesota Academy of Family Physicians (MAFP) lobbyist Dave Renner, CAE, shares a preview of the 2023 Minnesota legislative session and highlights the MAFP’s legislative priorities and engagement opportunities.

AAFP Federal Advocacy Team Update, July 2022

The American Academy of Family Physicians (AAFP) federal advocacy team shares an update about the release of the 2023 Medicare physician fee schedule, the Bipartisan Safer Communities Act which has now become law, the Supreme Court’s decision to strike down Roe v. Wade and its negative impact on the patient-physician relationship, the current state of the COVID-19 public health emergency and what’s to come as well as delays for the Appropriate Use Criteria Program.